Cardiol Therapeutics CRDL
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 1.07 | -0.12 | -10,180 | -10 | ||
| 2025Q2 | 1.36 | -0.10 | -7,676 | -8 | ||
| 2025Q1 | 0.97 | -0.10 | -8,429 | -8 | ||
| 2024Q4 | 1.28 | -9,989 | -8 | |||
| 2024Q3 | 1.98 | -0.18 | -14,140 | -13 | ||
| 2024Q2 | 2.02 | -0.10 | -7,741 | -7 | ||
| 2024Q1 | 1.81 | -0.14 | -8,405 | -9 | ||
| 2023Q4 | 0.84 | |||||
| 2023Q3 | 0.90 | -0.09 | -7,656 | -6 | ||
| 2023Q2 | 0.89 | -0.12 | -6,315 | -7 | ||
| 2023Q1 | 0.49 | -0.11 | -7,786 | -7 | ||
| 2022Q4 | 0.51 | -0.11 | -9,095 | -8 | ||
| 2022Q3 | 1.03 | -0.13 | -13,220 | -8 | ||
| 2022Q2 | 1.32 | -0.10 | -9,232 | -6 | ||
| 2022Q1 | 1.53 | -0.14 | -9,788 | -9 | ||
| 2021Q4 | 1.85 | -13,098 | -6 | |||
| 2021Q3 | 4.15 | -0.23 | -10,164 | -10 | ||
| 2021Q2 | -0.16 | -6,423 | -7 | |||
| 2021Q1 | -0.26 | -8,980 | -9 | |||
| 2020Q4 | -9,619 | -10 |